Skip to content
Peptilyze
Hormonal & reproductive

Melanotan II studies

219 journal papers mention Melanotan II in the title or abstract. Here are the most cited, the latest, and a few facts about the literature.

Studies range from laboratory work to clinical trials. A paper listed here is not an endorsement and says nothing about whether Melanotan II is safe, effective or approved for any use.

Compare Melanotan II prices, from €17.99 →

Papers
219
213 articles, 6 reviews
Earliest paper
1994
Most papers in 2012 (15)
Open access
48%
free to read somewhere
Reviews
3%
of all papers listed

What kind of studies

Of 199 papers in PubMed that mention Melanotan II in the title or abstract, by the study type PubMed records. Categories overlap, so they do not add up to the total.

  • Randomized controlled trials1
  • Other clinical trials3
  • Meta-analyses and systematic reviews0
  • Other reviews10
  • Case reports11
  • Animal studies only137
  • Studies in humans48

Study types are tags assigned by publishers and PubMed indexers; very new papers are often not tagged yet, and a tag is not a quality rating. Retracted papers are excluded. Source: PubMed (NCBI).

Registered clinical studies

Studies on ClinicalTrials.gov that mention Melanotan II in their intervention details. A registration says a study is planned or running, not what it found.

Registered
1
Completed
0
Ongoing or planned
1
Phase 1
0
Phase 2
1
Phase 3
0
  1. Melanotan II (MT-II) as an Adjunct to NB-UVB Phototherapy for Repigmentation in Stable Nonsegmental Vitiligo

    NCT07437560RecruitingPhase 2started 2026-02-02

The five most recently updated studies. See all 1 on ClinicalTrials.gov. Source: ClinicalTrials.gov (U.S. National Library of Medicine). Studies are found by the compound's name, so a few may be about something else.

Papers per year

1997 to 2026, peak 15 papers in a year. The latest year may still be incomplete.

1997: 1 papers1998: 2 papers1999: 2 papers2000: 4 papers2001: 2 papers2002: 4 papers2003: 13 papers2004: 6 papers2005: 14 papers2006: 7 papers2007: 15 papers2008: 15 papers2009: 10 papers2010: 7 papers2011: 9 papers2012: 15 papers2013: 5 papers2014: 11 papers2015: 12 papers2016: 5 papers2017: 5 papers2018: 8 papers2019: 4 papers2020: 9 papers2021: 9 papers2022: 5 papers2023: 1 papers2024: 9 papers2025: 4 papers2026: 2 papers19972026

Where it is published

  1. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology14 papers
  2. Endocrinology12 papers
  3. Peptides10 papers
  4. European Journal of Pharmacology6 papers
  5. The FASEB Journal6 papers

The papers

Most citedName in the title

  1. Evaluation of Melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study

    Robert T. Dorr, Ruskin R. Lines, Norman S. Levine et al. · Life Sciences · 1996

    Clinical trial · Phase 1136 citations

  2. Melanocortin receptor agonists, penile erection, and sexual motivation: human studies with Melanotan II

    Hunter Wessells, Norman S. Levine, Mac E. Hadley et al. · International Journal of Impotence Research · 2000

    Clinical trial118 citations

  3. Unabated anorexic and enhanced thermogenic responses to melanotan II in diet-induced obese rats despite reduced melanocortin 3 and 4 receptor expression

    G Li, Yaodan Zhang, JT Wilsey et al. · Journal of Endocrinology · 2004

    Animal studyOpen access56 citationsRead the open copy →

  4. The Melanocortin Agonist Melanotan‐II Reduces the Orexigenic and Adipogenic Effects of Neuropeptide Y (NPY) but Does not Affect the NPY‐Driven Suppressive Effects on the Gonadotropic and Somatotropic Axes in the Male Rat

    Paula Raposinho, R.B. White, Martine Aubert · Journal of Neuroendocrinology · 2003

    Animal studyOpen access · CC BY48 citationsRead the open copy →

  5. The melanocortin agonist, melanotan II, enhances proceptive sexual behaviors in the female rat

    Anne‐Sophie Rössler, James G. Pfaus, Hossein Kami Kia et al. · Pharmacology Biochemistry and Behavior · 2006

    Animal study43 citations

  6. Intracerebroventricular administration of melanotan II increases insulin sensitivity of glucose disposal in mice

    Annemieke C. Heijboer, Anita M. van den Hoek, Hanno Pijl et al. · Diabetologia · 2005

    Animal studyOpen access43 citationsRead the open copy →

  7. Melanocortinergic Activation by Melanotan II Inhibits Feeding and Increases Uncoupling Protein 1 Messenger Ribonucleic Acid in the Developing Rat

    Maria M. Glavas, Sandra E. Joachim, Shin J. Draper et al. · Endocrinology · 2007

    Animal study39 citations

  8. Food intake reductions and increases in energetic responses by hindbrain leptin and melanotan II are enhanced in mice with POMC-specific PTP1B deficiency

    Bart C. De Jonghe, Matthew R. Hayes, Derek J. Zimmer et al. · American Journal of Physiology-Endocrinology and Metabolism · 2012

    Animal studyOpen access35 citationsRead the open copy →

  9. Melanotan II injection resulting in systemic toxicity and rhabdomyolysis

    Michael E. Nelson, Sean M. Bryant, Steven E. Aks · Clinical Toxicology · 2012

    Case report34 citations

  10. Identification and characterization by LC‐UV‐MS/MS of melanotan II skin‐tanning products sold illegally on the Internet

    Torben Breindahl, Michael J. Evans-Brown, Peter Hindersson et al. · Drug Testing and Analysis · 2014

    Open access33 citationsRead the open copy →

  11. Melanoma Associated with the Use of Melanotan-II

    Kasper Fjellhaugen Hjuler, Henrik Frank Lorentzen · Dermatology · 2013

    Study in humans30 citations

  12. The medial preoptic nucleus as a site of the thermogenic and metabolic actions of melanotan II in male rats

    Boris Monge-Roffarello, Sébastien M. Labbé, Christophe Lenglos et al. · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · 2014

    Animal study29 citations

  13. Melanotan-II reverses autistic features in a maternal immune activation mouse model of autism

    Elena Minakova, Jordan Lang, Jesús‐Servando Medel‐Matus et al. · PLoS ONE · 2019

    Animal studyOpen access · CC BY20 citationsRead the open copy →

  14. 5-HT2C receptor activation is a common mechanism on proerectile effects of apomorphine, oxytocin and melanotan-II in rats

    Yasuharu Kimura, Yuki Naitou, Fumikazu Wanibuchi et al. · European Journal of Pharmacology · 2008

    Animal study20 citations

  15. Evidence that Melanocortin Receptor Agonist Melanotan-II Synergistically Augments the Ability of Naltrexone to Blunt Binge-Like Ethanol Intake in Male C57BL/6J Mice

    Montserrat Navarro, Francisca Carvajal, José Manuel Lerma-Cabrera et al. · Alcoholism Clinical and Experimental Research · 2015

    Animal studyOpen access19 citationsRead the open copy →

  16. The Use of Telemetry Technology to Test the Proerectile Effect of Melanotan-II (MT-II) in Conscious Rats

    Francois Giuliano, A-S. Rössler, Pierre Clément et al. · European Urology · 2005

    Animal study19 citations

  17. The protective effects of the melanocortin receptor (MCR) agonist, melanotan-II (MTII), against binge-like ethanol drinking are facilitated by deletion of the MC3 receptor in mice

    Jeffrey J. Olney, Gretchen M. Sprow, Montserrat Navarro et al. · Neuropeptides · 2013

    Animal studyOpen access17 citationsRead the open copy →

  18. Reduced Anorexigenic Efficacy of Leptin, But Not of the Melanocortin Receptor Agonist Melanotan-II, Predicts Diet-Induced Obesity in Rats

    Gertjan van Dijk, Koert de Vries, Csaba J. Nyakas et al. · Endocrinology · 2005

    Study in humansOpen access17 citationsRead the open copy →

  19. Eruptive naevi and darkening of pre-existing naevi 24 h after a single mono-dose injection of melanotan II

    Franziska Sophie Schulze, Hanieh Erdmann, Lena H. Hardkop et al. · European Journal of Dermatology · 2014

    Case report16 citations

  20. Melanotan-II: Investigation of the inducer and facilitator effects on penile erection in anaesthetized rat

    Francois Giuliano, Pierre Clément, Stéphane Droupy et al. · Neuroscience · 2005

    Animal study16 citations

  21. Melanotan II causes hypothermia in mice by activation of mast cells and stimulation of histamine 1 receptors

    Shalini Jain, Anna Panyutin, Naili Liu et al. · American Journal of Physiology-Endocrinology and Metabolism · 2018

    Animal studyOpen access15 citationsRead the open copy →

  22. The potent melanocortin receptor agonist melanotan-II promotes peripheral nerve regeneration and has neuroprotective properties in the rat

    Mariel ter Laak-Poort, Jan H. Brakkee, Roger A.H. Adan et al. · European Journal of Pharmacology · 2003

    Animal study15 citations

  23. Effects of melanotan II, a melanocortin agonist, on grooming and exploration in rats after repeated restraint/immobilization

    Věra Klenerová, Ivan Krejčı́, Pavel Šı́da et al. · Neuroscience Letters · 2007

    Animal study14 citations

  24. Preformulation Studies with Melanotan-II: A Potential Skin Cancer Chemopreventive Peptide

    En-Ling Lan, Sydney O. Ugwu, James D. Blanchard et al. · Journal of Pharmaceutical Sciences · 1994

    Animal study14 citations

  25. Analogue of Melanotan II (MTII): A Novel Melanotropin with Superpotent Action on Frog Skin

    Liqian Gao, Zhiqiang Yu, Dan Meng et al. · Protein and Peptide Letters · 2015

    Animal study13 citations

  26. Melanotan II: a possible cause of renal infarction: review of the literature and case report

    Björn Peters, Henrik Hadimeri, Rebecka Wahlberg et al. · CEN Case Reports · 2020

    ReviewOpen access12 citationsRead the open copy →

  27. The melanocortin agonist melanotan II increases insulin sensitivity in OLETF rats

    Ryouichi Banno, Hiroshi Arima, Ikuko Sato et al. · Peptides · 2004

    Animal study11 citations

  28. CLIPSing Melanotan-II to Discover Multiple Functionally Selective hMCR Agonists

    Stefano Tomassi, Marilisa Pia Dimmito, Minying Cai et al. · Journal of Medicinal Chemistry · 2022

    Study in humans10 citations

  29. Effects of Ghrelin, Corticotrophin-releasing Hormone, and Melanotan-II on Food Intake in Rats with Paraventricular Nucleus Lesions

    J. Wang, S. Ling, T. Usami et al. · Experimental and Clinical Endocrinology & Diabetes · 2007

    Animal study10 citations

  30. The first preparative solution phase synthesis of melanotan II

    Vladimir V. Ryakhovsky, Georgy A Khachiyan, Nina F Kosovova et al. · Beilstein Journal of Organic Chemistry · 2008

    Open access · CC BY9 citationsRead the open copy →

  31. Systemic Delivery of Melanotan II through the Ocular Route in Rabbits

    Sirirat Pinsuwan, Paul Brian Myrdal, Samuel H. Yalkowsky · Journal of Pharmaceutical Sciences · 1997

    Animal study9 citations

  32. Melanocortin receptor agonist melanotan-II microinjected in the nucleus accumbens decreases appetitive and consumptive responding for food

    Nicole L. Eliason, Lynne Martin, Malcolm James Low et al. · Neuropeptides · 2022

    Animal studyOpen access7 citationsRead the open copy →

  33. Melanotan II User Experience: A Qualitative Study of Online Discussion Forums

    Eimear Gilhooley, Selene Daly, Dermot B. McKenna · Dermatology · 2021

    Study in humans7 citations

  34. Dermatoskopische Veränderungen von melanozytären Nävi unter Verwendung von Melanotan II

    R. Mang, Dieter Krahl, Till Assmann · Der Hautarzt · 2012

    Case report7 citations

  35. 5‐Hydroxypyrroloindoline Affords Tryptathionine and 2,2′‐bis‐Indole Peptide Staples: Application to Melanotan‐II

    Mihajlo Todorovic, Antoine Blanc, Zhou Wang et al. · Chemistry - A European Journal · 2024

    Open access · CC BY5 citationsRead the open copy →

  36. Antidepressant-like and antistress effects of the ACTH(4–10) synthetic analogs Semax and Melanotan II on male rats in a model of chronic unpredictable stress

    Ludmila S. Inozemtseva, Ksenia A. Yatsenko, Н. Ю. Глазова et al. · European Journal of Pharmacology · 2024

    Animal study4 citations

  37. Inhibitory Effect of the Melanocortin Receptor Agonist Melanotan-II (MTII) on Feeding Depends on Dietary Fat Content and not Obesity in Rats on Free-Choice Diets

    José K. van den Heuvel, Leslie Eggels, Andrea J. van Rozen et al. · Frontiers in Behavioral Neuroscience · 2015

    Open access · CC BY3 citationsRead the open copy →

  38. Melanotan II, a melanocortin agonist, partially rescues the impaired thermogenic capacity of pituitary adenylate cyclase‐activating polypeptide deficient mice

    Thecla McMillan, Maeghan A. M. Forster, Landon I. Short et al. · Experimental Physiology · 2020

    Animal studyOpen access2 citationsRead the open copy →

  39. LC‐HRMS characterization of the skin pigmentation and sexual enhancers melanotan II and bremelanotide sold on the black market of performance and image enhancing drugs

    Serena Mestria, Sara Odoardi, Giampietro Frison et al. · Drug Testing and Analysis · 2020

    Study in humans2 citations

  40. Syntheses of Melanotan II and YSL Amide by Ajiphase® Methodology

    T. A. Sanguliya, Anna O. Antipova, Sergei V. Shkavrov et al. · Pharmaceutical Chemistry Journal · 2019

    2 citations

LatestName in title or abstract

  1. Peptides in urology and sexual medicine: clinical effectiveness, dosing, indications, and safety: a narrative review

    V Vasylieva, Annette West, Edward Karpman · Sexual Medicine Reviews · 2026

    Review

  2. Melanotan ii

    Reactions Weekly · 2026

  3. (349) Therapeutic Peptides in Sexual Medicine: A Narrative Review

    E Burchfiel, N Mills, G Saffati et al. · The Journal of Sexual Medicine · 2025

    ReviewOpen accessRead the open copy →

  4. 62185 Beliefs, Attitudes, and Experiences of Individuals using Melanotan II

    Ning C. McKenzie, Ning C. McKenzie, Nathaly Gonzalez et al. · Journal of the American Academy of Dermatology · 2025

  5. Association of tanning injection with hypercortisolism, hyperglycaemia and ketosis in type 1 diabetes mellitus

    Hnin Hnin Aung, Eingyin Ko Ko, Cornelius James Fernandez · British Journal of Diabetes · 2025

    Open access · CC BYRead the open copy →

  6. 98-OR: Melanocortin 4 Receptor–Mediated Effects Require Beta-Arrestin 2 Signaling

    Muaz Rashid, Oksana Gavrilova, Zhenzhong Cui et al. · Diabetes · 2025

    1 citations

  7. Antidepressant-like and antistress effects of the ACTH(4–10) synthetic analogs Semax and Melanotan II on male rats in a model of chronic unpredictable stress

    Ludmila S. Inozemtseva, Ksenia A. Yatsenko, Н. Ю. Глазова et al. · European Journal of Pharmacology · 2024

    Animal study4 citations

  8. Barbie drug identification: Not a child's play

    Marine Deville, Corinne Charlier · Journal of Forensic Sciences · 2024

    Case reportOpen access1 citationsRead the open copy →

  9. Recommended Tool Compounds for the Melanocortin Receptor (MCR) G Protein-Coupled Receptors (GPCRs)

    Nicholas A. Weirath, Carrie Haskell‐Luevano · ACS Pharmacology & Translational Science · 2024

    Open access5 citationsRead the open copy →

  10. Poster presentationsPS09 User experiences of Melanotan II injection for tanning

    Ning C. McKenzie, Nathaly Gonzalez, Cathleen Huang et al. · British Journal of Dermatology · 2024

    Open accessRead the open copy →

  11. Health Threat in the Tanning Trend

    Mohammed Al Abadie · Dermatology and Dermatitis · 2024

    Open accessRead the open copy →

  12. Therapeutic Strategies Against Metabolic Imbalance in a Male Mouse Model With 5-HT2CR Loss-of-Function

    Hailan Liu, Zhaoxun Liu, Huey-Xian Kelly Wong et al. · Endocrinology · 2024

    Animal studyOpen access2 citationsRead the open copy →

  13. Saisie de produits : identification inattendue ou erreur sur la marchandise

    Charline Bottinelli, Luc Rembault, Kévin Revelut et al. · Annales de Toxicologie Analytique · 2024

    1 citations

  14. Multiple metabolic signals in the CeA regulate feeding: The role of AMPK

    Gisele Castro, Natália Ferreira Mendes, Laís Weissmann et al. · Molecular and Cellular Endocrinology · 2024

    Animal study1 citations

  15. 5‐Hydroxypyrroloindoline Affords Tryptathionine and 2,2′‐bis‐Indole Peptide Staples: Application to Melanotan‐II

    Mihajlo Todorovic, Antoine Blanc, Zhou Wang et al. · Chemistry - A European Journal · 2024

    Open access · CC BY5 citationsRead the open copy →

  16. Melanotan-II reverses memory impairment induced by a short-term HF diet

    Patryk Wekwejt, Urszula Wojda, Anna Kiryk · Biomedicine & Pharmacotherapy · 2023

    Animal studyOpen access · CC BY-NC-ND1 citationsRead the open copy →

  17. Obesity medication lorcaserin activates brainstem GLP-1 neurons to reduce food intake and augments GLP-1 receptor agonist induced appetite suppression

    Stefan Wagner, Daniel I. Brierley, Alasdair T. S. Leeson-Payne et al. · Molecular Metabolism · 2022

    Study in humansOpen access · CC BY32 citationsRead the open copy →

  18. Vasopressin neurons in the paraventricular hypothalamus promote wakefulness via lateral hypothalamic orexin neurons

    Md Tarikul Islam, Florian Rumpf, Yusuke Tsuno et al. · Current Biology · 2022

    Open access37 citationsRead the open copy →

  19. Melanocortin receptor agonist melanotan-II microinjected in the nucleus accumbens decreases appetitive and consumptive responding for food

    Nicole L. Eliason, Lynne Martin, Malcolm James Low et al. · Neuropeptides · 2022

    Animal studyOpen access7 citationsRead the open copy →

  20. CLIPSing Melanotan-II to Discover Multiple Functionally Selective hMCR Agonists

    Stefano Tomassi, Marilisa Pia Dimmito, Minying Cai et al. · Journal of Medicinal Chemistry · 2022

    Study in humans10 citations

  21. Melanocortin 3/4 receptor in the dorsal raphe nucleus regulates maternal care in lactating mice

    Yoshikage Muroi, Toshiaki Ishii · Proceedings for Annual Meeting of The Japanese Pharmacological Society · 2022

    Open accessRead the open copy →

  22. Zebrafish Bioassay for Screening Therapeutic Candidates Based on Melanotrophic Activity

    Ted Inpyo Hong, Kyu-Seok Hwang, Tae‐Ik Choi et al. · International Journal of Molecular Sciences · 2021

    Study in humansOpen access · CC BY4 citationsRead the open copy →

  23. Intracerebroventricular administration of α-melanocyte-stimulating hormone (α-MSH) enhances thigmotaxis and induces anxiety-like behavior in the goldfish Carassius auratus

    Keisuke Watanabe, Norifumi Konno, Tomoya Nakamachi et al. · Peptides · 2021

    Animal studyOpen access13 citationsRead the open copy →

  24. Depletion of Alpha-Melanocyte-Stimulating Hormone Induces Insatiable Appetite and Gains in Energy Reserves and Body Weight in Zebrafish

    Yang-Wen Hsieh, Yi-Wen Tsai, Hsin-Hung Lai et al. · Biomedicines · 2021

    Open access · CC BY14 citationsRead the open copy →

  25. Evaluation of synthetic alpha-melanocyte-stimulating hormone analogs: An observational study of unregulated, online-available drugs

    Edward Kenji Hadeler, Karyn Haitz, Fleta Netter Bray · Journal of the American Academy of Dermatology · 2021

    Study in humansOpen access1 citationsRead the open copy →

  26. The Mesencephalic Trigeminal Nucleus Controls Food Intake and Body Weight via Hindbrain POMC Projections

    Samantha M. Fortin, Jack C. Chen, Harvey J. Grill et al. · Nutrients · 2021

    Animal studyOpen access · CC BY12 citationsRead the open copy →

  27. Melanoma In-Situ Associated with Melanotan Ii Use

    Mallalieu Jared E · Clinical Case Reports and Clinical Study · 2021

    Open access · CC BY1 citationsRead the open copy →

  28. Melanotan Tanning Injection: A Rare Cause of Priapism

    Chase W. Mallory, Diana M. Lopategui, Billy Hamilton Cordon · Sexual Medicine · 2021

    Case reportOpen access · CC BY-NC-ND8 citationsRead the open copy →

  29. Pharmacological chaperone action in humanized mouse models of MC4R-linked obesity

    Patricia René, Damien Lanfray, Denis Richard et al. · JCI Insight · 2021

    Study in humansOpen access · CC BY22 citationsRead the open copy →

  30. Melanotan II User Experience: A Qualitative Study of Online Discussion Forums

    Eimear Gilhooley, Selene Daly, Dermot B. McKenna · Dermatology · 2021

    Study in humans7 citations

  31. Melanotan II, a melanocortin agonist, partially rescues the impaired thermogenic capacity of pituitary adenylate cyclase‐activating polypeptide deficient mice

    Thecla McMillan, Maeghan A. M. Forster, Landon I. Short et al. · Experimental Physiology · 2020

    Animal studyOpen access2 citationsRead the open copy →

  32. LC‐HRMS characterization of the skin pigmentation and sexual enhancers melanotan II and bremelanotide sold on the black market of performance and image enhancing drugs

    Serena Mestria, Sara Odoardi, Giampietro Frison et al. · Drug Testing and Analysis · 2020

    Study in humans2 citations

  33. CAPS2 deficiency induces proopiomelanocortin accumulation in pituitary and affects food intake behavior in mice

    Shuhei Fujima, Natsuki Amemiya, Tomoki Arima et al. · Neuroscience Letters · 2020

    Animal study3 citations

  34. Development of Ligand-Drug Conjugates Targeting Melanoma through the Overexpressed Melanocortin 1 Receptor

    Yang Zhou, Saghar Mowlazadeh Haghighi, Zekun Liu et al. · ACS Pharmacology & Translational Science · 2020

    Open access11 citationsRead the open copy →

  35. Application of Dimedone Enamines as Protecting Groups for Amines and Peptides

    Sivanna Chithanna, Sameer Vyasamudri, Ding‐Yah Yang · Organic Letters · 2020

    15 citations

  36. Hypothalamic POMC deficiency increases circulating adiponectin despite obesity

    Hui Min Yu, Kavaljit H. Chhabra, Zoe Thompson et al. · Molecular Metabolism · 2020

    Animal studyOpen access · CC BY-NC-ND31 citationsRead the open copy →

  37. Sites and sources of sympathoexcitation in obese male rats: role of brain insulin

    Zhigang Shi, Ding Zhao, Priscila A. Cassaglia et al. · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · 2020

    Animal studyOpen access23 citationsRead the open copy →

  38. Topical MTII Therapy Suppresses Melanoma Through PTEN Upregulation and Cyclooxygenase II Inhibition

    Jian‐Ching Wu, Han‐En Tsai, Yi-Hsiang Hsiao et al. · International Journal of Molecular Sciences · 2020

    Study in humansOpen access · CC BY4 citationsRead the open copy →

  39. Melanotan II: a possible cause of renal infarction: review of the literature and case report

    Björn Peters, Henrik Hadimeri, Rebecka Wahlberg et al. · CEN Case Reports · 2020

    ReviewOpen access12 citationsRead the open copy →

  40. Syntheses of Melanotan II and YSL Amide by Ajiphase® Methodology

    T. A. Sanguliya, Anna O. Antipova, Sergei V. Shkavrov et al. · Pharmaceutical Chemistry Journal · 2019

    2 citations

Each list shows up to 40 papers.See all 219 on OpenAlex. Source: OpenAlex (CC0), journal articles and reviews with a DOI, retractions excluded, refreshed weekly, last 4 Nov 2026, 08:27 UTC. Papers are listed by their metadata only; follow the links to read them. A license shown on an open copy is the license the publisher or repository states for that copy.